[Microbiological etiology in children with community acquired pneumonia]

Ying-Jian Wang1, Jie Liu, Fang Fang

  • 1Kunming Maternal and Child Health Hospital, Kunming 650031, China. wyj0871@sina.com

Abstract

Insights

Respiratory syncytial virus and Streptococcus pneumoniae are key pathogens causing community-acquired pneumonia (CAP) in children. Infants under one year old face a higher infection risk from these and other microorganisms.

Area of Science:

  • Pediatric Infectious Diseases
  • Microbiology
  • Respiratory Medicine

Context:

  • Community-acquired pneumonia (CAP) is a significant cause of childhood illness.
  • Identifying causative pathogens is crucial for effective treatment and prevention strategies.
  • Understanding microbial distribution aids in developing targeted interventions.

Purpose:

  • To investigate the prevalence and distribution of various pathogenic microorganisms responsible for CAP in a pediatric population.
  • To identify the most common bacterial and viral agents contributing to CAP in children.
  • To assess the impact of age on the susceptibility to specific pathogens.

Summary:

  • A study of 1167 children with CAP identified Streptococcus pneumoniae (35.1%) and Respiratory Syncytial Virus (RSV) (19.3%) as the most prevalent pathogens.
  • Bacterial isolates included Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, and Moraxella catarrhalis, with 30.1% of top strains exhibiting antimicrobial resistance.
  • RSV and Streptococcus pneumoniae co-infection was observed in 35.2% of cases, and children under one year old showed a higher infection rate.

Impact:

  • This research highlights RSV and Streptococcus pneumoniae as primary drivers of pediatric CAP.
  • Findings underscore the increased vulnerability of infants to microbial infections.
  • Results inform clinical practice regarding empirical treatment and infection control measures for pediatric CAP.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: